Dr. Yu has been fortunate to have been mentored by, worked with and collaborated with some of the top cancer specialist in the United States and World Wide:
Dr. Bhadrrasain Vikram – Chief of the Clinical Radiation Oncology Branch at the NCI.
MD Dr. Vikram received his medical degree from the University of Delhi and trained in radiation oncology at Memorial Sloan-Kettering Cancer Center in New York City. He subsequently served on the faculties of Memorial Sloan-Kettering, Cornell University Medical College and Mount Sinai School of Medicine. From 1992-2003 he served as Professor and University Chair of the Department of Radiation Oncology at the Albert Einstein College of Medicine and Radiation Oncologist-in-Chief at the Montefiore Medical Center in New York City.
From 2003-2006 he served on the ACGME Residency Review Committee for Radiation Oncology. He has authored over 150 scientific publications and was listed as among the 1000 ‘Best Doctors in America’ by American Health magazine, a Reader’s Digest publication.
From 2002-2006 he worked at the International Atomic Energy Agency of the United Nations in Vienna, Austria, helping to establish or upgrade cancer therapy facilities in about 100 low and middle income countries, and founded the Program of Action for Cancer Therapy (PACT). In 2005 he shared in the Nobel Peace Prize awarded to the IAEA whose contribution to global cancer control was cited by the Nobel committee.
Since 2006 he has served as Chief of the Clinical Radiation Oncology Branch at the NCI, overseeing a portfolio of clinical research grants within the Radiation Research Program as well as assisting the Cancer Therapy Evaluation Program and the Coordinating Center for Clinical Trials with NCI’s cooperative clinical trials groups program. He also continues his work on improving cancer prevention and control worldwide.
Clifford A. Hudis, MD – CEO ASCO, Chief of Breast Medicine MSKCC
Dr. Hudis is a world renown expert in breast cancer and served as Chief of the Breast Medicine Service at Sloan Kettering from 1998 to 2016 when he became the CEO of the American Society of Clinical Oncology.
Peter M. Mauch, MD – Dana Farber Caner Institute, Brigham and Women’s Hopsital
Dr. Mauch received his MD from St. Louis University in 1974, and completed his residency at the Harvard Joint Center for Radiation Therapy. He joined DFCI and Brigham and Women’s Hospital as a staff physician in 1978. His expertise and research focus is on Hodgkin’s disease and non-Hodgkin’s lymphomas plus stem cells/ autologous bone marrow transplantation.
Michael DeAngelica, MD – Chair of Surgery MSKCC expert GI and Hepatobilliary surgery MSKCC.
Dr DeAngelica holds the Enid A. Haupt Chair in Surgery at Sloan Kettering and serve as Vice Chair of the MSKCC Research Council, is Program Director for training fellowships in Surgical Oncology and Hepatopancreatobiliary Surgery. He is Vice Chair of the National Comprehensive Cancer Network (NCCN) panel on Clinical Practice Guidelines in Hepatobiliary Cancers.
Bernadine R. Donahue, MD – NYU Langone and Maimonides Medical Center
Dr. Donahue is a preminent brain tumor expert who has served on the Brain Tumor Committee of the RTOG, She is Clinical Associate Professor of the Department of Radiation Oncology and has multiple
Board Certifications in Radiation Oncology, Internal Medicine and Palliative Medicine. She was trained at NYU and Boston. Dr. Donahue has special expertise in pediatric radiation oncology as well.
Carol S. Portlock, MD – MSKCC
Dr. Portlock has been a pioneer and specializes in the care of patients with Hodgkin and non-Hodgkin lymphoma, and she is board-certified in internal medicine and medical oncology. She collaborates with her colleagues to conduct clinical trials aimed at improving the outcome of patients with these diseases through the development and evaluation of new treatment regimens. She has become internationally known in her field, having served as a previous member of the Board of Scientific Counselors of the National Cancer Institute and the Oncologic Drug Advisory Committee of the US Food and Drug Administration.
David P. Kelsen, MD – Former Chief of GI oncology, MSKCC
Dr. Kelsen is a board-certified medical oncologist with clinical and research interests in the field of gastrointestinal malignancies. His clinical practice includes care of patients with gastrointestinal cancers, neuroendocrine tumors, and cancers of unknown primary site. He is a attending physician on the Gastrointestinal Oncology Service, which he served as Chief from 1991 to 2011. Dr. Kelsen also serves on Memorial Sloan Kettering’s Research Council, which oversees the clinical research portfolio, among other committees.
Mark G. Kris, MD – Chair, Thoracic Oncology at MSKCC
Dr. Kris is a medical oncologist who specializes in the care of people with cancers arising in the lungs. His research aims to discover better treatments for individuals with lung cancers by studying the genetic characteristics of their tumors. Dr. Kris also leads a research team working to find new genetic targets in cancer cells, and to test anticancer medicines that specifically attack the lung cancers driven by these molecular changes. He works with surgeons and radiation specialists to find the best ways to use surgery, radiotherapy, and drugs together to increase the chance of cure.
George Bosl, MD – Former Chair Solid Tumor at MSKCC, Bellevue.
Dr. Bosl is a medical oncologist in New York, New York and is affiliated with multiple hospitals in the area, including Bellevue Hospital Center and Memorial Sloan Kettering Cancer Center. He received his medical degree from Creighton University School of Medicine and has been in practice for more than 20 years. Dr. Bosl accepts several types of health insurance, listed below. He is one of 31 doctors at Bellevue Hospital Center and one of 12 at Memorial Sloan Kettering Cancer Center who specialize in Medical Oncology.
RADIATION ONCOLOGY
Bhadrrasain Vikram, MD
Dr. Vikram received his medical degree from the University of Delhi and trained in radiation oncology at Memorial Sloan-Kettering Cancer Center in New York City. He subsequently served on the faculties of Memorial Sloan-Kettering, Cornell University Medical College and Mount Sinai School of Medicine. From 1992-2003 he served as Professor and University Chair of the Department of Radiation Oncology at the Albert Einstein College of Medicine and Radiation Oncologist-in-Chief at the Montefiore Medical Center in New York City.
From 2003-2006 he served on the ACGME Residency Review Committee for Radiation Oncology. He has authored over 150 scientific publications and was listed as among the 1000 ‘Best Doctors in America’ by American Health magazine, a Reader’s Digest publication.
From 2002-2006 he worked at the International Atomic Energy Agency of the United Nations in Vienna, Austria, helping to establish or upgrade cancer therapy facilities in about 100 low and middle income countries, and founded the Program of Action for Cancer Therapy (PACT). In 2005 he shared in the Nobel Peace Prize awarded to the IAEA whose contribution to global cancer control was cited by the Nobel committee.
Since 2006 he has served as Chief of the Clinical Radiation Oncology Branch at the NCI, overseeing a portfolio of clinical research grants within the Radiation Research Program as well as assisting the Cancer Therapy Evaluation Program and the Coordinating Center for Clinical Trials with NCI’s cooperative clinical trials groups program. He also continues his work on improving cancer prevention and control worldwide.
Peter M. Mauch, MD
Dr. Mauch received his MD from St. Louis University in 1974, and completed his residency at the Harvard Joint Center for Radiation Therapy. He joined DFCI and Brigham and Women’s Hospital as a staff physician in 1978. His clinical research focuses on the treatment and long-term outcome of patients with early-stage Hodgkin’s disease and non-Hodgkin’s lymphoma. In the laboratory, he is studying the effects of cytotoxic agents and cytokines on hematopoietic stem cells and autologous bone marrow transplantation.
Board Certification – Radiation Oncology, 1978
Fellowship – Harvard Joint Center for Radiation Therapy, Radiation Oncology
Residency – Harvard Joint Center for Radiation Therapy, Radiation Oncology
Internship – St. Louis University School of Medicine, Internal Medicine, 1975
Medical School – Saint Louis University School of Medicine, 1974
Skyler K. Lindsley, MD
Dr. Lindsley is a radiation oncology specialist in Edmonds, Washington. She graduated with honors from Vanderbilt University School Of Medicine in 1985. Having more than 32 years of diverse experiences, especially in Radiation Oncology, Dr. Lindsley affiliates with many hospitals including Swedish Medical Center, Swedish Edmonds Hospital, and cooperates with other doctors and specialists in medical group Tumor Institute Physicians.
Bernadine R. Donahue, MD
Positions
Clinical Associate Professor, Department of Radiation Oncology
Board Certifications
American Board of Radiology (Hospice & Palliative Medicine), 2012
American Board of Radiology – Radiation Oncology, 1991
American Board of Internal Medicine – Internal Medicine, 1987
Education and Training
Residency, NYU Medical Center, Radiation Oncology, 1990
Residency, Boston University Medical Center, Internal Medicine, 1987
MD from Boston University, 1984
MEDICAL ONCOLOGY
Clifford A. Hudis, MD
Dr. Hudis served as Chief of the Breast Medicine Service from 1998 to 2016 when he became the CEO of the American Society of Clinical Oncology. He is a consultant medical oncologist with a clinical practice limited to the treatment of people with breast cancer.
Clinical Expertise: Breast Cancer
Education: MD, Medical College of Pennsylvania
Residencies: Internal Medicine – Hospital of the Medical College of Pennsylvania
Fellowships: Medical Oncology/Hematology – Memorial Sloan Kettering Cancer Center
Board Certifications: Internal Medicine; Medical Oncology
Carol S. Portlock, MD
Dr. Portlock specializes in the care of patients with Hodgkin and non-Hodgkin lymphoma, and she is board-certified in internal medicine and medical oncology. She collaborates with her colleagues to conduct clinical trials aimed at improving the outcome of patients with these diseases through the development and evaluation of new treatment regimens. She has become internationally known in her field, having served as a previous member of the Board of Scientific Counselors of the National Cancer Institute and the Oncologic Drug Advisory Committee of the US Food and Drug Administration.
David P. Kelsen, MD
Dr. Kelsen is a board-certified medical oncologist with clinical and research interests in the field of gastrointestinal malignancies. His clinical practice includes care of patients with gastrointestinal cancers, neuroendocrine tumors, and cancers of unknown primary site. He is a attending physician on the Gastrointestinal Oncology Service, which he served as Chief from 1991 to 2011. Dr. Kelsen also serves on Memorial Sloan Kettering’s Research Council, which oversees the clinical research portfolio, among other committees.
Mark G. Kris, MD
Dr. Kris is a medical oncologist who specializes in the care of people with cancers arising in the lungs. His research aims to discover better treatments for individuals with lung cancers by studying the genetic characteristics of their tumors. Dr. Kris also leads a research team working to find new genetic targets in cancer cells, and to test anticancer medicines that specifically attack the lung cancers driven by these molecular changes. He works with surgeons and radiation specialists to find the best ways to use surgery, radiotherapy, and drugs together to increase the chance of cure.
George Bosl, MD
Dr. Bosl is a medical oncologist in New York, New York and is affiliated with multiple hospitals in the area, including Bellevue Hospital Center and Memorial Sloan Kettering Cancer Center. He received his medical degree from Creighton University School of Medicine and has been in practice for more than 20 years. Dr. Bosl accepts several types of health insurance, listed below. He is one of 31 doctors at Bellevue Hospital Center and one of 12 at Memorial Sloan Kettering Cancer Center who specialize in Medical Oncology.
Tarek Elrafei, MD
Dr. Tarek Elrafei is a medical oncologist in Bronx, New York and is affiliated with multiple hospitals in the area, including Coney Island Hospital and Jacobi Medical Center. He received his medical degree from Nova Southeastern University College of Osteopathic Medicine and has been in practice for more than 20 years. Dr. Elrafei accepts several types of health insurance, listed below. He is one of 22 doctors at Coney Island Hospital and one of 3 at Jacobi Medical Center who specialize in Medical Oncology.
Kin Lui, MD
Education – MD, Bowman Gray School of Medicine, Winston-Salem
Residency – Montefiore Medical Center and Beth Israel Medical Center
SURGERY
Bradley Cohen, MD
Dr. Cohen is a surgeon in Bay Shore, New York and is affiliated with multiple hospitals in the area, including Good Samaritan Hospital Medical Center and Southside Hospital. He received his medical degree from Icahn School of Medicine at Mount Sinai and has been in practice for more than 20 years. Dr. Cohen accepts several types of health insurance, listed below. He is one of 14 doctors at Good Samaritan Hospital Medical Center and one of 37 at Southside Hospital who specialize in Surgery.